Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I W Campbell

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Epidemiology and clinical presentation of type 2 diabetesI W Campbell
International Journal of Clinical Practice|June 4, 2010
Comparing the actions of older and newer therapies on body weight: to what extent should these effects guide the selection of antidiabetic therapy?I W Campbell
International Journal of Clinical Practice|April 2, 2004
Long-term glycaemic control with pioglitazone in patients with type 2 diabetesI W Campbell
Journal of the American Geriatrics Society|October 1, 1974
Non-fatal ketoacidosis in a 94-year-old diabetic patientI W Campbell
Diabete & Metabolisme|May 1, 1991
Management of type 2 diabetes mellitus with special reference to metformin therapyI W Campbell
Acta Diabetologica Latina|January 1, 1976
The Somogyi phenomenon. A short reviewI W Campbell
Current Molecular Medicine|May 17, 2005
The Clinical Significance of PPAR Gamma AgonismI W Campbell
Hormone and Metabolic Research. Supplement Series|January 1, 1985
Metformin and the sulphonylureas: the comparative riskI W Campbell
Drugs|December 29, 2000
Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?I W Campbell
British Medical Journal (Clinical Research Ed.)|August 4, 1984
Metformin and glibenclamide: comparative risksI W Campbell
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Epidemiology and clinical presentation of type 2 diabetesI W Campbell
International Journal of Clinical Practice|June 4, 2010
Comparing the actions of older and newer therapies on body weight: to what extent should these effects guide the selection of antidiabetic therapy?I W Campbell
International Journal of Clinical Practice|April 2, 2004
Long-term glycaemic control with pioglitazone in patients with type 2 diabetesI W Campbell
Journal of the American Geriatrics Society|October 1, 1974
Non-fatal ketoacidosis in a 94-year-old diabetic patientI W Campbell
Diabete & Metabolisme|May 1, 1991
Management of type 2 diabetes mellitus with special reference to metformin therapyI W Campbell
Acta Diabetologica Latina|January 1, 1976
The Somogyi phenomenon. A short reviewI W Campbell
Current Molecular Medicine|May 17, 2005
The Clinical Significance of PPAR Gamma AgonismI W Campbell
Hormone and Metabolic Research. Supplement Series|January 1, 1985
Metformin and the sulphonylureas: the comparative riskI W Campbell
Drugs|December 29, 2000
Antidiabetic drugs present and future: will improving insulin resistance benefit cardiovascular risk in type 2 diabetes mellitus?I W Campbell
British Medical Journal (Clinical Research Ed.)|August 4, 1984
Metformin and glibenclamide: comparative risksI W Campbell
Pageof 14